News
Missing first screening appt raises breast cancer death risk – study
Women who miss their first mammogram face a 40 per cent higher risk of dying from breast cancer over 25 years, mainly because cancers are detected later, new research has found.
Nearly a third (32 per cent) of women invited to their first breast screening did not attend. These women were also less likely to take part in later screenings.
The findings suggest that targeting this group could cut breast cancer deaths across the population.
The researchers said: “Our study shows that first screening non-participants represent a large population at an elevated risk of dying from breast cancer decades in advance. This increased mortality is modifiable and primarily attributed to late detection.”
They added: “Targeted interventions are warranted to boost adherence to mammography screening and decrease the mortality risk for those who did not participate in the first screening.”
Swedish researchers analysed registry data from nearly half a million women invited to their first screening between 1991 and 2020, tracking them for up to 25 years.
The study measured screening attendance, breast cancer diagnoses, tumour characteristics and deaths, adjusting for social, economic, reproductive and health-related factors.
Women who skipped their first screening were more likely to be diagnosed with advanced breast cancer.
Over 25 years, their death rate was 9.9 per 1,000 women compared with 7 per 1,000 for those who attended.
Overall cancer rates were similar: 7.8 per cent for participants versus 7.6 per cent for non-participants. The higher death rate therefore reflects late detection rather than more cancers occurring.
Mammograms can detect cancer early, often before a lump can be felt, which improves treatment options and survival chances.
US researchers, writing in a linked editorial, said attending the first appointment is a long-term investment in breast health and survival.
They noted that the findings should help clinicians highlight the lasting impact on mortality when speaking with patients, while also supporting continued public funding for mammography services.
The said: “Ensuring that women are informed, supported, and empowered to participate in their first screening should be a shared goal across the healthcare system.”
The authors acknowledged some limits, including that the study was observational and so cannot prove cause and effect, and that results may not apply in countries with different healthcare systems, screening schedules or cultural attitudes to prevention.
Diagnosis
Researchers develop nasal therapeutic HPV vaccine
Researchers have created a therapeutic HPV vaccine delivered through the nose that could offer a non-invasive treatment for cervical cancer.
Screening for HPV and preventive vaccines lower risk, but there are no approved therapies for existing HPV infections or HPV-linked cancers.
Current treatments include surgery, radiotherapy and chemotherapy.
Researchers from Chiba University, Japan, led by associate professor Rika Nakahashi-Ouchida and Ms Hiromi Mori of Chiba University Hospital, have developed an intranasal therapeutic option.
Unlike injectable vaccines, nasal vaccines trigger immunity at the mucosal surface — the protective lining of the upper airway.
This mucosal response can also protect distant sites, including the reproductive tract.
Building on earlier work showing nasal immunisation can elicit strong genital-tract responses against herpes simplex virus type 2, the team used cationic nano-sized hydrogel particles (cCHP nanogels) to deliver HPV antigens to nasal tissues.
These positively charged spheres adhere to the negatively charged nasal surface and slowly release antigens, which prompt an immune response.
Nakahashi-Ouchida said: “We have developed an intranasal therapeutic vaccine as a non-surgical alternative to conventional treatments that can compromise women’s quality of life.
“This novel nasal vaccine activates the mucosal homing pathways of lymphocytes, allowing it to trigger an immune response in the cervical mucosa, a site from the nasal administration.”
The formulation targets the E7 oncoprotein from HPV16, which inactivates pRb, a key tumour suppressor.
To strengthen responses, the researchers added cyclic-di-AMP, an adjuvant that boosts T-cell-mediated immunity so T cells can attack infected or cancerous cells.
The resulting cCHP-E7 + c-di-AMP showed what the researchers describe as strong anti-tumour activity in mice and macaques. In mouse models, it significantly slowed tumour growth versus controls.
In macaques, a nasal spray device (usable in humans) delivered four doses.
Vaccinated animals developed high levels of E7-specific helper and killer T cells producing molecules linked to tumour control; controls did not.
Immune activity was detected in cervical tissue, and E7-specific killer T cells persisted for at least four months, suggesting lasting defence.
According to the World Health Organization, cervical cancer caused an estimated 660,000 new cases and 350,000 deaths in 2022.
If proven safe and effective in humans, intranasal therapy could offer a non-invasive, fertility-preserving alternative to surgery for some patients.
The cCHP nanogel platform may also support nasal vaccines against other pathogens and wider clinical uses.
Nakahashi-Ouchida said: “Immunotherapies such as intranasal therapeutic vaccines may help establish a new category of non-invasive treatment.
“These approaches could be extended to recurrence prevention and chronic disease management, offering patients safer and more accessible options.”
Hormonal health
Study reveals why women more likely to get severe long Covid
Opinion
Swimming, periods and finding freedom in my body
By WUKA sports ambassador, Hannah Miley MBE 3x Olympian & Commonwealth champion
I started swimming when I was really young, I just loved being in the water.
The pool quickly became my second home, the place where I felt most like myself. I wasn’t a natural swimmer, but I loved to work hard, and racing gave me that outlet for my competitive side.
There was something about the rhythm of the strokes, the smell of chlorine, and the quiet hum beneath the surface that made me feel free.
I got my first period around age 12, and it was daunting. My body was changing, and I didn’t know what that meant for my swimming.
Wearing a swimsuit every day made me feel exposed, and I just assumed everything I was going through (heavy bleeding that lasted up to two weeks, cramps so bad they left me doubled over) was normal.
There were moments that really knocked my confidence: not realising my tampon string was visible, or climbing out of the pool to find blood running down my leg.
At competitions, I’d sometimes sit on my towel because I’d leaked through.
The heavy bleeding left me anaemic and constantly tired, but I kept pushing through. I wanted to swim at the highest level I could even if it meant battling my body every month.
Competitions & The Pill
I’ll never forget the 2004 Commonwealth Youth Games. My period started mid-competition, and during one race, the cramps hit hard.
Swimming through that pain was frustrating, all that training felt wasted. When I saw my GP back home, I was told the best way to “fix my period problems” was to go on the pill.
Those two words, fix and problems, shaped how I thought about my body for years.
At first, the pill seemed like the perfect solution. No more painful, unpredictable periods! I ran packets back to back to skip bleeds during competitions, thinking I was being smart.
What I didn’t realise was that the seven day break wasn’t a real period at all, it was a withdrawal bleed. I thought I was in control of my cycle, but I was actually masking it.
I didn’t understand how important my hormones were for health, recovery, and performance.
On the surface, everything looked fine. Beneath that, I was struggling. Under-fuelling, getting ill before big meets, and picking up constant shoulder and knee niggles.
But I didn’t connect any of it to my hormonal health. The pill blurred the picture, and for years, I lived in fear of my period returning at the “wrong” time.
Nothing compares to the emotion you feel when you make an Olympic team.

When I realised I had qualified for my first Olympics in 2008, it was surreal the culmination of years of early mornings, long sessions, and relentless dedication.
Standing on the pool deck with “Team GB” on my kit felt like stepping into a dream that little Hannah could only have imagined.
Racing around the world, representing Scotland and Team GB, was the greatest honour of my career.
Each competition taught me more about resilience, discipline, and the incredible things the human body can do when you push it to its limits.
I went on to swim at three Olympic Games, and while each one was different, they all shaped me not just as an athlete, but as a person learning to listen to and respect her body.
It wasn’t until 2020, during lockdown, that I finally came off the pill after more than 15 years. I was speaking to Dr Georgie Bruinvels when she asked a simple but powerful question:
“When was the last time you actually had a period?”
That question stopped me in my tracks. The answer? Not since before I started the pill as a teenager, over 15 years ago.
I learned that I should have taken longer breaks to let my hormones reset after five years.
It was probably mentioned when I first started but at 15 the chances of me remembering were going to be slim. I wished someone had reminded me.
For the first time, I began tuning into my body, tracking my cycle, adjusting my nutrition, and paying attention to the signals I’d ignored for so long. The difference was incredible.
My periods now last about five days, my cramps are mild and manageable, and I finally feel in sync with my body instead of fighting against it. And no little pill to remember to take each day.
The knowledge I have now would’ve been game changing for me as a young athlete.
Finding Freedom Again — This Time, on My Period
WUKA Sports Ambassador
Becoming a WUKA Sports Brand Ambassador felt like everything coming full circle.
To work with a company whose values aligned with my mission, supporting and empowering female athletes was incredible.
As an athlete, I only ever used tampons because I thought that was my only option.
But discovering products like period underwear and period swimwear has completely changed how I feel about my body and my period.

The first time I tried WUKA period pants, I couldn’t believe how comfortable they were. No rustling, no movement, and no fear of leaks. I actually forgot I was wearing them!
And their period swimwear? Game changer. No more worrying about climbing out of the pool and noticing blood running down my leg just confidence and freedom.
I can’t help but think how different my experience as a teenager could have been if products like this had existed then.
They would’ve given me comfort, reassurance, and a sense that my period wasn’t something to hide or fear.
That’s why I’m so passionate about opening up conversations around periods in sport.
For so many young athletes, missing training isn’t an option, but competing while bleeding can be stressful and distracting.
Period-proof swimwear can take away that anxiety — letting you focus on your performance, not your period.
What I’ve Learned
My journey has taught me that periods aren’t a “problem” to be fixed, they’re a natural, powerful part of who we are.
With the right knowledge, support, and tools, we can work with our bodies, not against them.
Period proof swimwear might seem like a small thing, but for a young swimmer, it can mean the world. It can mean the difference between fear and freedom, between shame and Confidence.
Periods are not the enemy of performance.
Ignoring them is.
Find out more about Wuka at wuka.co.uk
-
News3 weeks agoDozens of women report suffering painful burns after using Always sanitary towels
-
Wellness4 weeks agoCutting through the noise in femtech – key takeaways from Women’s Health Week 2025
-
Fertility in Focus3 weeks agoAI embryo selection tool wins European approval
-
News6 days agoOpinion: Not ‘just stress’ – How hormonal changes affect women’s brain function
-
News3 weeks agoTestosterone patch shows promise for menopausal women
-
News4 weeks agoScientists develop breakthrough approach to detecting endometriosis in menstrual blood
-
Wellness3 weeks agoFrom SEO to GEO: How women’s health brands can get found in the age of AI
-
News3 weeks agoFDA approves new menopause drug to treat hot flashes and night sweats






1 Comment